BR0211090A - Formulação farmacêutica que contém um antagonista de ltb4 - Google Patents
Formulação farmacêutica que contém um antagonista de ltb4Info
- Publication number
- BR0211090A BR0211090A BR0211090-3A BR0211090A BR0211090A BR 0211090 A BR0211090 A BR 0211090A BR 0211090 A BR0211090 A BR 0211090A BR 0211090 A BR0211090 A BR 0211090A
- Authority
- BR
- Brazil
- Prior art keywords
- formulation containing
- pharmaceutical formulation
- ltb4 antagonist
- antagonist
- ltb4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 239000005557 antagonist Substances 0.000 title abstract 3
- 150000002615 leukotriene B4 derivatives Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
"FORMULAçãO FARMACêUTICA QUE CONTéM UM ANTAGONISTA DE LTB~ 4~". A invenção refere-se a uma nova formulação farmacêutica que contém um antagonista de LTB~ 4~ de fórmula I onde [e] A, R~ 1~, R~ 2~, R~ 3~ e R~ 4~ têm os significados dados na reivindicação 1, bem como ao uso dessa formulação como composições farmacêuticas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10134377 | 2001-07-14 | ||
DE10206241A DE10206241A1 (de) | 2001-07-14 | 2002-02-15 | Arzneimittelformulierung enthaldend einen LTB Antagonisten |
PCT/EP2002/007618 WO2003007922A2 (de) | 2001-07-14 | 2002-07-09 | Arzneimittelformulierung enthaltend einen ltb4 antagonisten |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211090A true BR0211090A (pt) | 2004-06-15 |
Family
ID=26009704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211090-3A Expired - Fee Related BR0211090A (pt) | 2001-07-14 | 2002-07-09 | Formulação farmacêutica que contém um antagonista de ltb4 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1408943B1 (pt) |
JP (1) | JP2005502630A (pt) |
KR (1) | KR100912196B1 (pt) |
CN (1) | CN1298316C (pt) |
AT (1) | ATE298564T1 (pt) |
AU (1) | AU2002333235B2 (pt) |
BR (1) | BR0211090A (pt) |
CA (1) | CA2452357A1 (pt) |
ES (1) | ES2244821T3 (pt) |
HU (1) | HUP0401371A3 (pt) |
IL (1) | IL159493A0 (pt) |
MX (1) | MXPA04000384A (pt) |
NZ (1) | NZ530973A (pt) |
PL (1) | PL368613A1 (pt) |
RU (1) | RU2004102399A (pt) |
UY (1) | UY27376A1 (pt) |
WO (1) | WO2003007922A2 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10232120A1 (de) | 2002-07-16 | 2004-02-05 | Fev Motorentechnik Gmbh | Verfahren und Vorrichtung zum künstlichen Altern eines Kraftfahrzeugkatalysators |
RS20050390A (en) * | 2002-11-26 | 2008-04-04 | Boehringer Ingelheim Pharma Gmbh. & Co.Kg., | Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor |
US20070237823A1 (en) * | 2004-05-04 | 2007-10-11 | Thomas Bock | Solid Pharmaceutical Form Comprising and Ltb4 Antagonist |
CN110869362A (zh) | 2017-05-12 | 2020-03-06 | 国立研究开发法人理化学研究所 | A类gpcr结合性化合物改性体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5451700A (en) * | 1991-06-11 | 1995-09-19 | Ciba-Geigy Corporation | Amidino compounds, their manufacture and methods of treatment |
SK281016B6 (sk) * | 1992-02-05 | 2000-10-09 | Boehringer Ingelheim Kg | Amidínové deriváty, spôsob ich výroby, použitie a farmaceutické prostriedky s ich obsahom |
DE4424713A1 (de) * | 1994-07-13 | 1996-01-18 | Boehringer Ingelheim Kg | Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe |
DE19546452A1 (de) * | 1995-12-13 | 1997-06-19 | Boehringer Ingelheim Kg | Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel |
DE19636689A1 (de) * | 1996-09-10 | 1998-03-12 | Boehringer Ingelheim Kg | Neue Benzamidinderivate |
DE19637123A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Ingelheim Kg | Neue Pyranosidderivate |
DE19948428A1 (de) * | 1999-10-07 | 2001-04-12 | Boehringer Ingelheim Pharma | Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel |
-
2002
- 2002-07-09 IL IL15949302A patent/IL159493A0/xx unknown
- 2002-07-09 NZ NZ530973A patent/NZ530973A/en unknown
- 2002-07-09 WO PCT/EP2002/007618 patent/WO2003007922A2/de active IP Right Grant
- 2002-07-09 AU AU2002333235A patent/AU2002333235B2/en not_active Ceased
- 2002-07-09 RU RU2004102399/15A patent/RU2004102399A/ru not_active Application Discontinuation
- 2002-07-09 HU HU0401371A patent/HUP0401371A3/hu unknown
- 2002-07-09 BR BR0211090-3A patent/BR0211090A/pt not_active Expired - Fee Related
- 2002-07-09 EP EP02787119A patent/EP1408943B1/de not_active Expired - Lifetime
- 2002-07-09 KR KR1020047000585A patent/KR100912196B1/ko not_active IP Right Cessation
- 2002-07-09 CN CNB028139763A patent/CN1298316C/zh not_active Expired - Fee Related
- 2002-07-09 MX MXPA04000384A patent/MXPA04000384A/es active IP Right Grant
- 2002-07-09 AT AT02787119T patent/ATE298564T1/de not_active IP Right Cessation
- 2002-07-09 CA CA002452357A patent/CA2452357A1/en not_active Abandoned
- 2002-07-09 ES ES02787119T patent/ES2244821T3/es not_active Expired - Lifetime
- 2002-07-09 PL PL02368613A patent/PL368613A1/xx not_active Application Discontinuation
- 2002-07-09 JP JP2003513531A patent/JP2005502630A/ja active Pending
- 2002-07-11 UY UY27376A patent/UY27376A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20040016988A (ko) | 2004-02-25 |
NZ530973A (en) | 2006-07-28 |
WO2003007922A3 (de) | 2003-04-17 |
PL368613A1 (en) | 2005-04-04 |
CN1298316C (zh) | 2007-02-07 |
JP2005502630A (ja) | 2005-01-27 |
ES2244821T3 (es) | 2005-12-16 |
WO2003007922A2 (de) | 2003-01-30 |
RU2004102399A (ru) | 2005-05-27 |
CA2452357A1 (en) | 2003-01-30 |
ATE298564T1 (de) | 2005-07-15 |
AU2002333235B2 (en) | 2007-07-12 |
UY27376A1 (es) | 2003-02-28 |
HUP0401371A3 (en) | 2010-01-28 |
HUP0401371A2 (hu) | 2004-12-28 |
IL159493A0 (en) | 2004-06-01 |
EP1408943B1 (de) | 2005-06-29 |
EP1408943A2 (de) | 2004-04-21 |
MXPA04000384A (es) | 2004-05-04 |
KR100912196B1 (ko) | 2009-08-14 |
CN1527705A (zh) | 2004-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY29007A1 (es) | Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica | |
ATE469136T1 (de) | Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1 | |
BR0316532A (pt) | Composições farmacêuticas compreendendo, um composto de droga básico, respectivamente um ácido, um tensoativo e um ácido solúvel em água fisiologicamente tolerável, respectivamente, uma base | |
BR0116402A (pt) | Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular | |
BR0111639A (pt) | Uso de uma molécula de ácido oligodeoxinucléico, e composição farmacêutica contendo a mesma | |
SV1999000118A (es) | Nuevos derivados de pirazol substituidos ref. lea 33188-sv | |
BR0111206A (pt) | Derivados de arilmetilamina para uso como inibidores de triptase | |
DE60305724D1 (de) | Tetrahydrochinolin-derivate als crth2 antagonisten | |
BR9714390A (pt) | Combinações de substâncias ativas fungicidas | |
BR9811818A (pt) | Uso de um composto, composto, e, composição farmacêutica | |
BRPI0108395B8 (pt) | derivados de pirrolopirimidinona, processos de preparação e uso | |
ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
WO2001043704A8 (en) | A skin care composition that mediates cell to cell communication | |
BR9916004A (pt) | Inibidores de proteinase c de pró-colágeno | |
BR0209064A (pt) | Hidroxamatos de alquila tricìclicos, sua preparaçãoe seu uso como inibidores de proliferação de células | |
BR0316609A (pt) | Sinomenina e compostos de sinomenina, sìntese e uso | |
BR0314898A (pt) | Compostos, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica | |
BRPI0417833A (pt) | novos derivados de benzofurano, os quais podem ser usados na profilaxia ou tratamento de distúrbios relacionados com o receptor 5-ht6 | |
BR0212075A (pt) | Combinações de substâncias ativas fungicidas | |
BR0111678A (pt) | Composições medicinais contendo derivados de propenona | |
BR0311222A (pt) | R-enantiÈmeros de derivados de piranoindol contra hepatite c, seu método de obtenção e composição farmacêutica compreendendo os mesmos | |
BR0110699A (pt) | Combinações de substâncias ativas fungicidas | |
BR0100691A (pt) | Preparação cosmética ou dermatológica, e, uso da mesma | |
BR0208566A (pt) | Derivados de beta-carbolina | |
BR0211090A (pt) | Formulação farmacêutica que contém um antagonista de ltb4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A A NUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |